Valuation Roche Holding AG Swiss Exchange

Stocks

Market Closed - Swiss Exchange Other stock markets 11:31:20 2026-06-15 am EDT			5-day change	1st Jan Change
326.10 ^CHF	-1.18%		+0.89%	-0.64%

06:56am	Global drugmakers invest billions to boost US presence	RE
12:51am	Swiss stocks - Factors to watch on June 15	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	306,810	239,812	197,073	205,191	262,098	259,974	-	-
Change	-	-21.84%	-17.82%	4.12%	27.73%	-0.81%	-	-
Enterprise Value (EV) ¹	324,977	255,396	215,772	222,528	278,258	270,287	263,412	255,476
Change	-	-21.41%	-15.51%	3.13%	25.04%	-2.86%	-2.54%	-3.01%
P/E Ratio	23.4x	18.9x	17.1x	24.8x	20.5x	17.7x	16.5x	15.2x
PBR	13.2x	8.29x	5.91x	5.67x	7.8x	6.52x	5.51x	4.68x
PEG	-	-3.69x	-2.48x	-0.9x	0.4x	1.1x	2.23x	1.74x
Capitalization / Revenue	4.89x	3.79x	3.36x	3.39x	4.26x	4.15x	3.99x	3.8x
EV / Revenue	5.17x	4.04x	3.67x	3.68x	4.52x	4.32x	4.04x	3.74x
EV / EBITDA	13.2x	10.2x	9.82x	9.45x	11.3x	10.6x	9.68x	8.84x
EV / EBIT	14.8x	11.5x	11.2x	10.7x	12.7x	12x	10.9x	9.89x
EV / FCF	20.7x	19.6x	19.1x	14.5x	23.6x	16.9x	15.6x	14x
FCF Yield	4.83%	5.11%	5.23%	6.89%	4.24%	5.9%	6.4%	7.14%
Dividend per Share ²	9.3	9.5	9.6	9.7	9.8	10.03	10.28	10.56
Rate of return	2.45%	3.27%	3.93%	3.8%	2.99%	3.04%	3.11%	3.2%
EPS ²	16.2	15.37	14.31	10.31	16.04	18.64	20.02	21.76
Distribution rate	57.4%	61.8%	67.1%	94.1%	61.1%	53.8%	51.3%	48.5%
Net sales ¹	62,801	63,281	58,716	60,495	61,516	62,581	65,133	68,351
EBITDA ¹	24,692	25,015	21,976	23,538	24,608	25,465	27,203	28,889
EBIT ¹	21,897	22,173	19,240	20,823	21,833	22,565	24,231	25,827
Net income ¹	13,930	12,421	11,498	8,277	12,880	15,156	16,221	17,488
Net Debt ¹	18,167	15,584	18,699	17,337	16,160	10,313	3,438	-4,498
Reference price ²	379.10	290.50	244.50	255.50	328.20	330.00	330.00	330.00
Nbr of stocks (in thousands)	800,952	800,579	798,652	796,789	796,317	795,618	-	-
Announcement Date	2/3/22	2/2/23	2/1/24	1/30/25	1/29/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.15x	12.05x	24.81x	0.6%	1,010B
JOHNSON & JOHNSON	25.74x	5.93x	16.13x	2.22%	580B
ABBVIE INC.	27.88x	6.79x	13.86x	3.01%	402B
NOVARTIS AG	21.24x	5.49x	13.32x	2.92%	281B
ASTRAZENECA PLC	22.78x	4.74x	13.47x	1.85%	280B
NOVO NORDISK A/S	12.7x	4.75x	9.72x	3.95%	197B
AMGEN INC.	23.09x	6.16x	10.76x	2.84%	192B
GILEAD SCIENCES, INC.	-45x	5.43x	29.95x	2.58%	156B
PFIZER INC.	12.26x	3.2x	7.8x	6.68%	149B
Average	14.87x	6.06x	15.54x	2.96%	360.86B
Weighted average by Cap.	22.70x	7.59x	17.65x	2.21%